Valuation of the EQ-5D-3L in Jordan

被引:0
作者
Al Rabayah, Abeer [1 ,11 ]
Roudijk, Bram [2 ]
Purba, Fredrick Dermawan [3 ]
Rencz, Fanni [4 ]
Jaddoua, Saad [5 ]
Siebert, Uwe [1 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] UMIT TIROL Univ Hlth Sci & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol Ass, Dept Publ Hlth Hlth Serv Res & Hlth Technol Assess, Hall In Tirol, Austria
[2] EuroQol Res Fdn, Rotterdam, Netherlands
[3] Padjadjaran State Univ, Fac Psychol, Bandung, Indonesia
[4] Corvinus Univ Budapest, Dept Hlth Policy, Budapest, Hungary
[5] King Hussein Canc Ctr, Pharm Dept, Amman, Jordan
[6] ONCOTYROL Ctr Personalized Canc Med, Div Hlth Technol Assessment, Innsbruck, Austria
[7] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Dept Epidemiol, Boston, MA USA
[8] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA
[9] Harvard Med Sch, Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA USA
[10] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA
[11] King Hussein Canc Ctr, Ctr Drug Policy & Technol Assessment, Pharm Dept, Amman, Jordan
关键词
EQ-5D-3L; Jordan; Cost-utility; Virtual interviews; Valuation; Hybrid model; I19; TIME TRADE-OFF; HEALTH STATES; VALUE SET; VALUES; VERSION; CHOICE;
D O I
10.1007/s10198-024-01712-z
中图分类号
F [经济];
学科分类号
02 ;
摘要
BackgroundIn Jordan, no national value set is available for any preference-accompanied health utility measure.ObjectiveThis study aims to develop a value set for EQ-5D-3L based on the preferences of the Jordanian general population.MethodsA representative sample of the Jordanian general population was obtained through quota sampling involving age, gender, and region. Participants aged above 18 years were interviewed via videoconferencing using the EuroQol Valuation Technology 2.1 protocol. Participants completed ten composite time trade-offs (cTTO) and ten discrete choice experiments (DCE) tasks. cTTO and DCE data were analyzed using linear and logistic regression models, respectively, and hybrid models were applied to the combined DCE and cTTO data.ResultsA total of 301 participants with complete data were included in the analysis. The sample was representative of the general population regarding region, age, and gender. All model types applied, that is, random intercept model, random intercept Tobit, linear model with correction for heteroskedasticity, Tobit with correction for heteroskedasticity, and all hybrid models, were statistically significant. They showed logical consistency in terms of higher utility decrements with more severe levels. The hybrid model corrected for heteroskedasticity was selected to construct the Jordanian EQ-5D-3L value set as it showed the best fit and lowest mean absolute error. The predicted value for the most severe health state (33333) was - 0.563. Utility decrements due to mobility had the largest weight, followed by anxiety/depression, while usual activities had the smallest weight.ConclusionThis study provides the first EQ-5D-3L value set in the Middle East. The Jordanian EQ-5D-3L value set can now be used in health technology assessments for health policy planning by the Jordanian health sector's decision-makers.
引用
收藏
页码:487 / 501
页数:15
相关论文
共 67 条
[1]   The validity and reliability of the Arabic version of the EQ-5D: a study from Jordan [J].
Aburuz, Salah ;
Bulatova, Naela ;
Twalbeh, Mohammed ;
Gazawi, Moatasem .
ANNALS OF SAUDI MEDICINE, 2009, 29 (04) :304-308
[2]   A national survey of Iranian general population to estimate a value set for the EQ-5D-5L [J].
Afshari, Somayeh ;
Daroudi, Rajabali ;
Goudarzi, Reza ;
Mahboub-Ahari, Alireza ;
Yaseri, Mehdi ;
Sari, Ali Akbari ;
Ameri, Hosein ;
Bahariniya, Sajjad ;
Oliaei-Manesh, Alireza ;
Kalavani, Khalil ;
Zare, Zahra ;
Hasannezhad, Elham ;
Mirzaei, Mohammadamin ;
Amiri, Zahra .
QUALITY OF LIFE RESEARCH, 2023, 32 (07) :2079-2087
[3]   Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study [J].
Al Sayah, Fatima ;
Bansback, Nick ;
Bryan, Stirling ;
Ohinmaa, Arto ;
Poissant, Lise ;
Pullenayegum, Eleanor ;
Xie, Feng ;
Johnson, Jeffrey A. .
QUALITY OF LIFE RESEARCH, 2016, 25 (07) :1679-1685
[4]   Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study [J].
Al Shabasy, Sahar ;
Al Sayah, Fatima ;
Abbassi, Maggie ;
Farid, Samar .
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2022, 15 (05) :589-598
[5]   The EQ-5D-5L Valuation Study in Egypt [J].
Al Shabasy, Sahar A. ;
Abbassi, Maggie M. ;
Finch, Aureliano Paolo ;
Baines, Darrin ;
Farid, Samar F. .
PHARMACOECONOMICS, 2022, 40 (04) :433-447
[6]   Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study [J].
Al-jedai, Ahmed ;
Almudaiheem, Hajer ;
Al-Salamah, Tareq ;
Aldosari, Muath ;
Almutairi, Abdulaali R. ;
Almogbel, Yasser ;
AlRuthia, Yazed ;
Althemery, Abdullah U. ;
Alluhidan, Mohammed ;
Roudijk, Bram ;
Purba, Fredrick Dermawan ;
Awad, Nancy ;
O'jeil, Rita .
VALUE IN HEALTH, 2024, 27 (05) :552-561
[7]  
[Anonymous], 2018, EQ-5D-3L User Guide
[8]   A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states [J].
Badia, X ;
Roset, M ;
Herdman, M ;
Kind, P .
MEDICAL DECISION MAKING, 2001, 21 (01) :7-16
[9]   Can Life Expectancy and QALYs Be Improved by a Framework for Deciding Whether to Apply Clinical Guidelines to Patients With Severe Comorbid Disease? [J].
Braithwaite, R. Scott .
MEDICAL DECISION MAKING, 2011, 31 (04) :582-595
[10]   A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models [J].
Brazier, John ;
Ara, Roberta ;
Rowen, Donna ;
Chevrou-Severac, Helene .
PHARMACOECONOMICS, 2017, 35 :S21-S31